<SEC-DOCUMENT>0001213900-26-037501.txt : 20260331
<SEC-HEADER>0001213900-26-037501.hdr.sgml : 20260331
<ACCEPTANCE-DATETIME>20260331163014
ACCESSION NUMBER:		0001213900-26-037501
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260331
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260331
DATE AS OF CHANGE:		20260331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIUS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0001851484
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				994362660
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41534
		FILM NUMBER:		26822449

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6677

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		FIRST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TenX Keane Acquisition
		DATE OF NAME CHANGE:	20210315
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0284321-8k_citius.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-roles="http://fasb.org/us-roles/2026" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:CTOR="http://citiusonc.com/20260331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2026 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_CTOR_citiusonc.com_20260331 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20260331_20260331 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001851484 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001851484</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ctor-20260331.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851484</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-31</xbrli:startDate>
        <xbrli:endDate>2026-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20260331__20260331_zGif6V4DRoE5"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">the Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<b><span style="text-decoration: underline"><span id="xdx_904_edei--DocumentPeriodEndDate_c20260331__20260331_zERgtcezNBR3"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 31, 2026</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityRegistrantName_c20260331__20260331_zLSBTU9S5gX5"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000011" name="dei:EntityRegistrantName">Citius Oncology, Inc.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20260331__20260331_zjfDCFt0tUV9"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of incorporation)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20260331__20260331_zIn3Ks4FLE66"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000013" name="dei:EntityFileNumber">001-41534</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20260331__20260331_zTT2yM66UML"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000014" name="dei:EntityTaxIdentificationNumber">99-4362660</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer <br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20260331__20260331_z5H2Lt1nvjlj"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000015" name="dei:EntityAddressAddressLine1">11 Commerce Drive</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20260331__20260331_zRYKfTviesDf"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000016" name="dei:EntityAddressAddressLine2">1st Floor</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20260331__20260331_z57kf87kUvi1"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000017" name="dei:EntityAddressCityOrTown">Cranford</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20260331__20260331_zr2KSlDKlgW8"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20260331__20260331_zUR0YZyXzU95"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000019" name="dei:EntityAddressPostalZipCode">07016</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code <b><span style="text-decoration: underline">(<span id="xdx_903_edei--CityAreaCode_c20260331__20260331_zDFmUxlccbsf"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000020" name="dei:CityAreaCode">908</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20260331__20260331_zmq6GU9IDtXl"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000021" name="dei:LocalPhoneNumber">967-6677</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20260331__20260331_zLmlmvgUPmR9"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20260331__20260331_zxkFXLW3dDzl"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20260331__20260331_zoDnOvLzVXFa"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20260331__20260331_zTvygQxXSSN8"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--Security12bTitle_c20260331__20260331_zW51iLZxC3nc"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--TradingSymbol_c20260331__20260331_zViBbH8OfZe3"><ix:nonNumeric contextRef="AsOf2026-03-31" id="Fact000027" name="dei:TradingSymbol">CTOR</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>The <span id="xdx_906_edei--SecurityExchangeName_c20260331__20260331_z3rlV3rxWVIj"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20260331__20260331_zkIqLOWoVQ48"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityExTransitionPeriod_c20260331__20260331_zdOEIOxh70V"><ix:nonNumeric contextRef="AsOf2026-03-31" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -58.5pt">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 31, 2026, we issued a press release announcing
a commercial update on the U.S. launch of LYMPHIR&#8482; (denileukin diftitox-cxdl). A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-size: 10pt">Exhibit No.</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea028432101ex99-1.htm">Press release, dated March 31, 2026.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 40%"><span style="font-size: 10pt"><b>CITIUS ONCOLOGY, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: March 31, 2026</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ Leonard Mazur</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Leonard Mazur</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZl9ofddGlpRaxihQRt4NNZbCdlMyo9Uje0rFFDIGQvPflCeGLgtaqRYbzqirhiF3fSotQYYOM+oLOkW22KbhZ4VUZy1Lbcf2BGTkGHbMMFtLdR+dDGaxTCJNZEs3iJYSLdD6Hw054Xz0j3agatVWyBalrODD1rNBKfk0fjnIgTd1rTDohG0U6hSgIJ/kNcRjFsKeHfBLfDJRlJjx/LE8UTPfeufLBov6SkLfYuTgz0f/2Ps35SmA= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea028432101ex99-1.htm
<DESCRIPTION>PRESS RELEASE, DATED MARCH 31, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ea028432101_ex99-1img1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Citius Oncology Provides Commercial Update on
LYMPHIR&trade; Launch Highlighting Early <BR>
Adoption and Expanding Clinical Development</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Broad institutional uptake among leading cancer
centers and payer coverage supports early <BR>
prescribing momentum and clinical integration</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CRANFORD, N.J.</B>, March 31, 2026 &ndash;
Citius Oncology, Inc. (&ldquo;Citius Oncology&rdquo;) (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned
subsidiary of Citius Pharmaceuticals, Inc. (&ldquo;Citius Pharma&rdquo;) (Nasdaq: CTXR), today provided a commercial update on the U.S.
launch of LYMPHIR&trade; (denileukin diftitox-cxdl) for the treatment of cutaneous T-cell lymphoma (CTCL), highlighting continued adoption
across leading oncology centers, broad payer coverage progress, and advancing investigator-led clinical studies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We are encouraged by the early commercial
indicators for LYMPHIR, including the pace of formulary adoption, breadth of payer coverage, and increasing repeat orders from leading
oncology centers,&rdquo; said Leonard Mazur, Chairman and CEO of Citius Oncology and Citius Pharma. &ldquo;As our commercial organization
continues to scale and institutions complete formulary inclusion, we expect continued expansion in prescribing activity, including into
community settings. Together with further clinical validation through ongoing investigator-led studies, these trends support LYMPHIR&rsquo;s
potential not only for continued integration in the CTCL treatment landscape, but also its potential as a part of a combination immunotherapy
regimen in other cancers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Key Early Launch Metrics:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sequential growth in orders from target institutions
since launch, with initial accounts already placing repeat orders, indicating early prescribing continuity;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Strong institutional uptake, with 83% of target
accounts having added or actively progressing LYMPHIR through formulary review;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Broad and expanding market access with ~135 health
plans, representing ~80% of covered lives, secured and reimbursement systems established;</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No reported reimbursement denials or prior authorization
barriers;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increasing demand for in-services and clinical
education; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial penetration into community infusion centers
underway with patients beginning to transition from larger cancer centers; and, </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commercial buildout proceeding, with field team
onboarding in the coming month and broader field expansion in progress with our contracted sales organization.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Commercial Execution Advancing with Expanding
Market Access and Field Deployment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Commercial execution continues to advance with
the onboarding of field teams, targeted deployment of medical education and digital campaigns, attendance at major medical meetings and
increasing interaction with physicians, pharmacy stakeholders, and community centers to support the finalization of order sets and initiate
patient treatment, which typically precedes broader patient start acceleration following formulary inclusion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Commercial supply remains well positioned to support
anticipated U.S. demand, and international expansion is underway through executed distribution agreements across Europe and the Middle
East.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Clinical Development Expands Through Leading
Academic Collaborations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In parallel, Citius Oncology is advancing LYMPHIR&rsquo;s
clinical development through collaborations with leading academic centers to further evaluate its potential across broader oncology settings.
At the University of Minnesota, an investigator-sponsored study is evaluating LYMPHIR prior to CAR-T therapy in relapsed/refractory diffuse
large B-cell lymphoma, with positive topline data presented at the ASTCT 2026 Annual Meeting and additional analyses underway. At UPMC,
a Phase I study evaluating LYMPHIR in combination with pembrolizumab in solid tumors has been completed, with positive topline results
submitted for presentation at an upcoming oncology conference. Discussions are ongoing regarding next-stage development. These efforts
support a broader strategy to evaluate LYMPHIR as a potential combination therapy across immuno-oncology settings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Together, these commercial and clinical developments support a disciplined
launch trajectory and provide a solid foundation for continued adoption of LYMPHIR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About LYMPHIR&trade; (denileukin diftitox-cxdl)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR is a targeted immune therapy for relapsed
or refractory cutaneous T-cell lymphoma (CTCL) indicated for use in Stage I-III disease after at least one prior systemic therapy. It
is a recombinant fusion protein that combines the IL-2 receptor binding domain with diphtheria toxin (DT) fragments. The agent specifically
binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis.
After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis, resulting in cell death. Denileukin
diftitox-cxdl demonstrated the ability to deplete immunosuppressive regulatory T lymphocytes (Tregs) and antitumor activity through a
direct cytocidal action on IL-2R-expressing tumors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2021, denileukin diftitox received regulatory
approval in Japan for the treatment of relapsed or refractory CTCL and peripheral T-cell lymphoma (PTCL). Subsequently, in 2021, Citius
acquired an exclusive license with rights to develop and commercialize denileukin diftitox in all markets except for India, Japan and
certain parts of Asia. LYMPHIR (denileukin diftitox-cxdl) was approved by the FDA and subsequently launched in the U.S. in December 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Citius Oncology, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Citius Oncology, Inc. (Nasdaq: CTOR) is a platform
to develop and commercialize novel targeted oncology therapies. In December 2025, Citius Oncology launched LYMPHIR, approved by the FDA
for the treatment of adults with relapsed or refractory Stage I&ndash;III CTCL who had had at least one prior systemic therapy. Management
estimates the initial market for LYMPHIR currently exceeds $400 million, is growing, and is underserved by existing therapies. Robust
intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology
use as a combination therapy with checkpoint inhibitors would further support Citius Oncology&rsquo;s competitive positioning. For more
information, please visit www.citiusonc.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release may contain &ldquo;forward-looking
statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these
statements by the fact that they use words such as &ldquo;will,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;plan,&rdquo; &ldquo;should,&rdquo; and &ldquo;may&rdquo; and other words and terms of similar meaning or use of future dates. Forward-looking
statements are based on management&rsquo;s current expectations and are subject to risks and uncertainties that could negatively affect our
business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those
currently anticipated are: our ability to successfully commercialize LYMPHIR and establish a sustainable revenue stream; risks relating
to the results of research and development activities, including those from our existing and any new pipeline assets; our need for substantial
additional funds and our ability to raise additional money to fund our operations for at least the next 12 months as a going concern;
the estimated markets for LYMPHIR and our product candidates and the acceptance thereof by any market; early-stage clinical data may not
be predictive of results from larger or later-stage studies; our ability to maintain Nasdaq&rsquo;s continued listing standards; our ability
to secure strategic partnerships and expand international access to LYMPHIR; our ability to use the latest technology to support our commercialization
efforts for LYMPHIR; physician and patient acceptance of LYMPHIR in a competitive treatment landscape; our reliance on third-party logistics
providers, distributors, and specialty pharmacies to support commercial operations; our ability to educate providers and payers, secure
adequate reimbursement, and maintain uninterrupted product supply; post-marketing requirements and ongoing regulatory compliance related
to LYMPHIR; the ability of LYMPHIR and our product candidates to impact the quality of life of our target patient populations; our ability
to procure cGMP commercial-scale supply; our ability to obtain, perform under and maintain financing and strategic agreements and relationships;
market and other conditions; risks related to our growth strategy; patent and intellectual property matters; government regulation; as
well as other risks described in our Securities and Exchange Commission (&ldquo;SEC&rdquo;) filings. These risks have been and may be
further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future
performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described
in detail in our SEC filings which are available on the SEC&rsquo;s website at www.sec.gov, including in Citius Oncology&rsquo;s Annual
Report on Form 10-K for the year ended September 30, 2025, filed with the SEC on December 23, 2025. These forward-looking statements speak
only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances
on which any such statement is based, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LYMPHIR&trade; (denileukin diftitox-cxdl)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>INDICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR is an IL2-receptor-directed cytotoxin
indicated for the treatment of adult patients with r/r Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic
therapy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IMPORTANT SAFETY INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>BOXED WARNING: CAPILLARY LEAK SYNDROME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Capillary leak syndrome (CLS), including life-threatening
or fatal reactions, can occur in patients receiving LYMPHIR. Monitor patients for signs and symptoms of CLS during treatment. Withhold
LYMPHIR until CLS resolves, or permanently discontinue based on severity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WARNINGS AND PRECAUTIONS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Capillary Leak Syndrome</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR can cause capillary leak syndrome (CLS),
including life-threatening or fatal reactions. CLS was defined in the clinical trials as the occurrence of at least 2 of the following
symptoms at any time during LYMPHIR therapy: hypotension, edema, and serum albumin &lt;3 g/dL. These symptoms were not required to occur
simultaneously to be characterized as capillary leak syndrome.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As defined, CLS occurred in 27% of patients in
the pooled population across 3 clinical trials, including 8% with Grade 3. There was one (0.8%) fatal occurrence of CLS. Of the patients
with CLS, 22% had recurrence. The majority of CLS events (81%) occurred within the first 2 cycles of treatment. The median time to onset
from Cycle 1, Day 1 was 6.5 days (range: 1 to 77), the median duration of CLS was 14 days (range: 2 to 40), and 75% of patients had resolution.
The most common symptoms included edema, hypoalbuminemia, and hypotension. Pleural effusion, pericardial effusion, and dehydration also
occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regularly assess patients for weight gain, new
onset or worsening of edema, dyspnea, and hypotension (including orthostatic changes). Monitor serum albumin levels prior to the initiation
of each cycle of therapy and more often as clinically indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Withhold, reduce dose, or permanently discontinue
based on severity. If LYMPHIR is withheld, resume LYMPHIR following resolution of CLS and when serum albumin is greater than or equal
to 3 g/dL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Visual Impairment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR can cause serious visual impairment, including
changes in visual acuity and color vision. In the pooled population across 3 clinical trials, visual impairment occurred in 9%, with Grade
1 in 8% and Grade 2 in 1%. The most commonly reported symptom was blurred vision. Of the patients with visual impairment, 67% had resolution
of their visual impairment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Perform baseline ophthalmic examination and monitor
as clinically indicated. If patients experience symptoms of visual impairment, such as changes in visual acuity, changes in color vision,
or blurred vision, refer for ophthalmologic evaluation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Withhold LYMPHIR until visual impairment resolves
or permanently discontinue based on severity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Infusion-Related Reactions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR can cause serious infusion-related reactions.
Infusion-related reactions were reported in 69% of patients in the pooled population across 3 clinical trials of patients who received
LYMPHIR, with Grade 3 infusion-related reactions in 3.4%. Eighty-three percent of infusion-related reactions occurred in Cycles 1 and
2. The most common symptoms included nausea, fatigue, chills, musculoskeletal pain, vomiting, fever, and arthralgia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Premedicate patients for the first three cycles
prior to starting a LYMPHIR infusion. Monitor patients frequently during infusion. For Grade 2 or higher infusion reactions, premedicate
at least 30 minutes prior to each subsequent infusion with a systemic steroid for at least 3 cycles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interrupt or discontinue LYMPHIR based on severity.
Institute appropriate medical management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hepatotoxicity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LYMPHIR can cause hepatotoxicity. In the pooled
safety population, elevated ALT occurred in 70% of patients, with Grade 3 ALT occurring in 22%; elevated AST occurred in 64% of patients,
with Grade 3 AST elevation occurring in 9%. For Grade 3 events, median time to onset was 8 days (range: 1 to 15 days); median time to
resolution was 15 days (range: 7 to 50 days); all cases of Grade 3 ALT or AST elevations resolved. Elevated total bilirubin occurred in
5% of patients, with Grade 3 occurring in 0.9%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Monitor liver enzymes and bilirubin at baseline
and during treatment as clinically indicated. Withhold, reduce dose, or permanently discontinue LYMPHIR based on severity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Embryo-Fetal Toxicity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on its mechanism of action, LYMPHIR can
cause fetal harm when administered to a pregnant woman. Verify the pregnancy status of females of reproductive potential prior to the
initiation of LYMPHIR. Advise pregnant women of the potential risk to the fetus. Advise females of reproductive potential to use effective
contraception during treatment and for 7 days following the last dose of LYMPHIR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ADVERSE REACTIONS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The most common adverse reactions (&ge;20%), including
laboratory abnormalities, are increased transaminases, albumin decreased, nausea, edema, hemoglobin decreased, fatigue, musculoskeletal
pain, rash, chills, constipation, pyrexia, and capillary leak syndrome.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>USE IN SPECIFIC POPULATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Pregnancy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risk Summary</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on its mechanism of action, LYMPHIR can
cause fetal harm when administered to a pregnant woman. There are no available data on the use of LYMPHIR in pregnant women to evaluate
for a drug-associated risk. No animal reproductive and developmental toxicity studies have been conducted with denileukin diftitox.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Denileukin diftitox-cxdl causes depletion of regulatory
T lymphocytes (Treg), immune activation, and capillary leak syndrome, compromising pregnancy maintenance. Advise pregnant women of the
potential risk to a fetus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the U.S. general population, the estimated
background risk of major birth defects and miscarriage in clinically recognized pregnancies are 2-4% and 15-20%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Lactation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risk Summary</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No data are available regarding the presence of
denileukin diftitox-cxdl in human milk, the effects on the breastfed child, or on milk production. Because of the potential for serious
adverse reactions in breastfed children, advise women not to breastfeed during treatment with LYMPHIR and for 7 days after the last dose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Females and Males of Reproductive Potential
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on its mechanism of action, LYMPHIR can
cause fetal harm when administered to a pregnant woman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Pregnancy Testing </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Verify the pregnancy status of females
of reproductive potential prior to initiating LYMPHIR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Contraception</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Females </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advise females of reproductive potential to use
effective contraception during treatment with LYMPHIR and for 7 days after the last dose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Infertility</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Males</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on findings in rats, male fertility may
be compromised by treatment with LYMPHIR. The reversibility of the effect on fertility is unknown.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Pediatric Use</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Safety and effectiveness of LYMPHIR in pediatric
patients have not been established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Geriatric Use</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Of the 69 patients with Stage I-III r/r CTCL who
received LYMPHIR, 34 patients (49%) were 65 years of age and older and 10 patients (14%) were 75 years of age and older. Clinical studies
of LYMPHIR did not include sufficient numbers of patients 65 years of age and older to determine whether they respond differently from
younger adult patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You may report side effects to the FDA at 1-800-FDA-1088
or www.fda.gov/medwatch. You may also report side effects to Citius Oncology at 1-844-459-6744.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please read Important Safety Information and full
Prescribing Information, including Boxed WARNING, for LYMPHIR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ilanit Allen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@citiuspharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">908-967-6677 x113</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">STiR-communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greg Salsburg</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greg@STiR-communications.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ea028432101_ex99-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028432101_ex99-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !N +0# 2(  A$! Q$!_\0
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MSPS\:? &@_$#1-!U]K9]9TG3]>M1<V]EJ36;R6K7<*G;*T#M&3RIP: /?_\
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M_@]2_P"4@O[.W_9L%G_ZL#Q77](O_!G_ /\ *'?1/^SDOCC_ .C/"M?S=?\
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MM,U'4_$'C+5-(MU\27%Y>3ZU;_V'I^F:MI=I#!9&ZO3J"W1MH?VT_P"#L?\
MX)(_&W]N7X5?!;]JK]EWP5>?$CXM?LV6'BSPG\0OAMX?MX[CQGXU^$/BB[T[
M6K+5O"=FL8N]?U3X<^(K/5+R7PQ:RR7VH:-XOUO4-+MY[S239:C_  6?L._\
M%*OV]/\ @E)\2M?O_P!G'XA>(/AA>:AJ$,?Q)^#_ (\\.G5O OBV\TQ+BSBM
M_&GP_P#$4$+VVJ622R6\>KZ6^A>*+-4%O!J\$2&(@'^@/\<_^#.+_@EQ\0]*
M2/X/>)?VA/V?=?2;3B+[2?'MO\1]"EM(+@OJ,5SHGC_3=1U(WNH6Q-O#>6WB
M6VMK"41W/]FW0$D$W]5'@CP=X?\ AYX,\(^ /">GQ:3X5\#>&- \'^&=*M\^
M1IGA_P ,Z5::)HNGP ](;+3;&VMHQ@82,=Z_C#_X)T?\'DGP%^,6N>'OAC_P
M4#^$J_LV^)]7N;'2K;XY?#J_U+Q9\$[G4+NXBMDN?&/AG4DD\:?#+30TJ^=J
MEMJ/Q#TF!5FOM7O/#^G122Q?VIZ/J^E>(-)TS7M"U*PUG0];T^RU?1M8TN[M
M]0TS5M)U*VBO=.U/3;^UDEMKVPO[.>&ZM+NWDD@N+>6.:&1XW5V -&BBB@ H
MHHH \B_: ^'B?%SX$?&GX5R(9%^)/PI^(7@38LLD!9O%GA/5M"0":(-)$=]\
MO[R-6=/O*K$ '_#F^%OC'QA^R3^U#X)\:75OJ%CXS_9Y^->D:CK>E6%W<:=>
M2ZE\./&,2>)?#C7!%O-'!JBZ7J.@W\%S&L5S97=S:7UNT$LT#?[NIP!D]/\
M//X=?:O\UG_@Z'_X(8?%#X2_&OXA?\%&?V8O!&H^-/@%\4]0?Q5\>_"_A/3+
MK4-8^#7CVZ6-=<\;76EV2332_#GQ;<C^U=0UFT@6W\+:W<7G]L"#3KVWO4/P
M]-'\FK-/LTTT[---)I-)JSLT]&FDTT]+----.]FFFFKIIIM/^D+X7_\ !/1=
M(_X*#_LR_M4_LMR6WB;]C7XN1O\ M%>&?%?A:>"[\,^#-+\2>%)M?L/#5K=6
MY\IO"7BR'Q)9ZAX#:V62WCTYFTIVC6S@+_TPID @C^+@#L#@<=. <\]P,\]_
M\B[_ ():?\')O[;O_!,KX<6?P'M-+\+?M#_L^Z/=7-QX0^'OQ.O=7M]5^'4=
M]<F[O],\"^,--EDO],\.SW<MQ?+X9O[34=)M+ZZNKC2X]--W<B7]8?&__![=
M^TKJ/AZZM/ '[&7P<\->)9K6..UUOQ!XX\7>)-/L+HAQ-<_V/;6FCM=IS&88
M)-0@4$-YCNORMZ.8YIB\U^IO&2C.>#PD,)"I:TZE.$Y3C*K)WYZKYE&4OM*$
M6[R<F_'RC(L!D?UZ.7P=*ECL;4QTZ.GLZ-2I3A3=.C%)<E%-2E"#ORNI*,6H
M1A&/^@=^T;_R;W\=_;X-_$[/_A$ZV?Y5_C ?\$AO^4K'_!-G_L^O]E+_ -7A
MX(K_ %I/V</VN+']NK_@DWH_[5L$.EV-_P#%[]E/QQKWBG2=(N4N;'0?&EIX
M*\0Z3XRT1&6:<P_V7XCT_4K8VTTK36RHL4QWJ:_R6O\ @D-_RE8_X)L_]GV?
MLHC\_CCX(XY]>GKZ<UYQ[)_MS5_)O_P>1?\ **3PQ_V=%\+_ /U'_'%?UD5_
M)M_P>1D#_@E+X8!(!/[47PP !/)/_"/^.3@>O )X[#- 'X(_\&2W_)^G[67_
M &:(_P#ZN7X9U_I;U_FD?\&2W_)^O[6/_9HC_P#JY?AG7^EO0!_F5?\ !ZE_
MRD%_9V_[-@L__5@>*Z_I$_X,_P X_P"".VB'&?\ C)+XX_EYOA7/KG [=^E?
MS=_\'J)'_#P;]G<9Z?LP66?4?\7 \5]OI7](O_!G\0?^".^BX[?M)_'$'V/F
M>%3_ "(/XT ?Q#?\'.'AR^\._P#!:[]LA;[&-;O_ (6^(K)A'*@>PU;X/^!9
M(2#*B"0H\<L+O$9(C)&ZJY975?\ 20_X(+_$73_B=_P2&_84\1:;!]FCT_X)
MZ7X1NK<W$5RT>H>"]1U+PS>9>$L$,TVF&<1.%EB654= 1S_,Q_P>%?\ !*[X
MK_$3Q!X _P""D_P,\&ZYX[T?PKX"M/A5^TMHWAVUN=6UGPGH?AW4K_4? 7Q1
M_LBU26\G\,10ZUJOAOQCJ%I%(OA];7PYJ=]&FESZI?Z=_/C_ ,$E_P#@XI_:
MX_X)3_#_ %+X'^'/"/@KXY? 2]\0W7B?2_A[X\N=4TF_\%ZQJKJ^NS^$/$VC
MEKFTL]9E1+N\TK4+/4++[>KW5K]DDN+@R ']NG_!W/XWL/"W_!'OQKH,VKV-
MAJ7CWXU_![P]INGW+D76M)9ZS>Z_J-MI\85C)+:VVE"]G)VK';PR,S E0W\R
M_P#P98Z9?W7_  46^/VI06<TUCI?[*>MC4+M IALVOOB/X"ALQ,Q8%3<R)(D
M04,24;. I-?D7_P5F_X+=_M6_P#!7O7/ .E?%/1?#/PX^%WPZO;Z]\$_!_X=
M-K%SI,GB75V-H_B/7;[4YYK[Q#XA%@8M*L)/L]K!9PO=+9VB27LQ/]O'_!IS
M_P $K?B1^Q%^S5\1OVGOVA?"&H>!OC7^U@?#<7AGP+XCTEM,\7> O@KX4:_O
M-#7Q':WD46J:'K/Q!UO4YO$5]X=O$AFLM%TCPC+J%O!JDEW9V8!_6Z<]AU//
M..,8R/TKX$_:Y_X)>_L%?MR:1J]C^TI^S-\-?'6KZO:SVS^.X-#MO#GQ'L))
M3*PO[#QWH"Z?XACO8)9'GADN+VYB,I'G0R(2E?RY?\'#O_!P#^V!_P $X?\
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MM-MDAM-?^*7CC5[[Q=XZNK9UQ)=Z9I>LZQ+X:\/WUPJ7=SX:T'1GNHXIM\:
M'Z,T444 %%%% !4<L44T<D,L:2Q2QO%)'(BO')%(NV2-T<,CHZDJR,I5E)#
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MO*I9OFN+P6)S&5*6+IX*C0P6&51RG*M.E6<JE3V4W3A%1NDKR;G%+^YOX=?
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MO&7P$_8M^#7ACQQH0@;1?'7B'2M2^)/C31KJWF$\6HZ+XG^)>I^+M7T/55F
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M/,'F4\3@_JJQM64<6I<DI0OBXTJ5:4'6O*,7-4;RND_@W]CCXIZS^SU\(?\
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'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ctor-20260331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /K4ps7xRiXgen8uGZHRMOa2P+aP9wpV7aZkxvWR2HdnqDy0uRGWRYSDwivUWMVIA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:CTOR="http://citiusonc.com/20260331" elementFormDefault="qualified" targetNamespace="http://citiusonc.com/20260331">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://citiusonc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ctor-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ctor-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
    <import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
    <import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd" />
    <import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
    <import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ctor-20260331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ctor-20260331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="ctor-20260331.xsd#Cover" roleURI="http://citiusonc.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://citiusonc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Citius Oncology, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001851484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">99-4362660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11 Commerce Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">1st Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-6677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTOR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0284321-8k_citius.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://citiusonc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ctor-20260331.xsd</File>
    <File>ctor-20260331_lab.xml</File>
    <File>ctor-20260331_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0284321-8k_citius.htm">ea0284321-8k_citius.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0284321-8k_citius.htm": {
   "nsprefix": "CTOR",
   "nsuri": "http://citiusonc.com/20260331",
   "dts": {
    "schema": {
     "local": [
      "ctor-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ctor-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctor-20260331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0284321-8k_citius.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 24
   },
   "report": {
    "R1": {
     "role": "http://citiusonc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-03-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0284321-8k_citius.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-03-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0284321-8k_citius.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CountryRegion",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Extension",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12gTitle",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://citiusonc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-26-037501-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-037501-xbrl.zip
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ME+L"P&I+=WVC,(A.MSEJ??D;?>UIR+_<1H_2% %>2+#+7 _]-I/F\%_7!(%
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M^P3*_IR3UC3NS.1S-Z&LZZBX#SF>'(W]YWO>T-5$&T5B4];$R83RO/[OUN;
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M,ZE=N:E,>WAZXDDD*;[C*C\0S(=6\?]02P,$%     @ QH-_7-+H'PF''P
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M$X6FN&RIF+SC>]T],U09[U11S<#K@9^E&.  7F+9%7X5?<FQO%?ID(%%?BL
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M4$L! A0#%     @ QH-_7&S@WC(L P  Y0L  !$              ( !
M &-T;W(M,C R-C S,S$N>'-D4$L! A0#%     @ QH-_7-?P#?3]"@  ?X8
M !4              ( !6P,  &-T;W(M,C R-C S,S%?;&%B+GAM;%!+ 0(4
M Q0    ( ,:#?USW$R3R60<  -97   5              "  8L.  !C=&]R
M+3(P,C8P,S,Q7W!R92YX;6Q02P$"% ,4    " #&@W]<GT< @_X0  #56P
M%P              @ $7%@  96$P,C@T,S(Q+3AK7V-I=&EU<RYH=&U02P$"
M% ,4    " #&@W]<TN@?"8<?  "JI   %0              @ %*)P  96$P
H,C@T,S(Q,#%E>#DY+3$N:'1M4$L%!@     %  4 30$   1'      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ea0284321-8k_citius_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctor-20260331.xsd" xlink:type="simple"/>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851484</identifier>
        </entity>
        <period>
            <startDate>2026-03-31</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-03-31" id="Fact000004">0001851484</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-03-31" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-03-31" id="Fact000010">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-03-31" id="Fact000011">Citius Oncology, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-03-31" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-03-31" id="Fact000013">001-41534</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-03-31" id="Fact000014">99-4362660</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-03-31" id="Fact000015">11 Commerce Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-03-31" id="Fact000016">1st Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-03-31" id="Fact000017">Cranford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-03-31" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-03-31" id="Fact000019">07016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-03-31" id="Fact000020">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-03-31" id="Fact000021">967-6677</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-03-31" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-03-31" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-03-31" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-03-31" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-03-31" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-03-31" id="Fact000027">CTOR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-03-31" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-03-31" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2026-03-31" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
